Australia markets closed

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.92-0.81 (-3.91%)
At close: 04:00PM EDT
19.92 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-179,272
-151,759
-112,033
-100,777
-79,207
Depreciation & amortisation
19
29
43
41
17
Stock-based compensation
24,051
21,497
23,243
10,054
6,022
Change in working capital
9,449
-6,670
-4,459
9,727
2,085
Accounts payable
6,442
-645
968
3,273
2,481
Other working capital
-155,875
-145,367
-92,517
-79,681
-70,952
Other non-cash items
699
1,019
421
203
196
Net cash provided by operating activities
-155,875
-145,367
-92,517
-79,681
-70,804
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-148
Purchases of investments
-447,189
-433,123
-101,446
-43,561
-115,037
Sales/maturities of investments
263,825
209,500
37,621
85,841
105,424
Net cash used for investing activities
-183,364
-223,623
-63,825
42,280
-9,761
Cash flows from financing activities
Common stock issued
690,872
335,429
241,200
0
202,554
Other financing activities
-747
-776
-864
-521
52
Net cash used provided by (used for) financing activities
705,101
353,316
255,632
602
203,107
Net change in cash
365,862
-15,674
99,290
-36,799
122,542
Cash at beginning of period
257,992
249,881
150,591
187,390
64,848
Cash at end of period
623,854
234,207
249,881
150,591
187,390
Free cash flow
Operating cash flow
-155,875
-145,367
-92,517
-79,681
-70,804
Capital expenditure
-
-
-
-
-148
Free cash flow
-155,875
-145,367
-92,517
-79,681
-70,952